Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1974 Dec;30(6):571–576. doi: 10.1038/bjc.1974.237

Serum Oestradiol-17β in Women with Benign and Malignant Breast Disease

P C England, L G Skinner, K M Cottrell, R A Sellwood
PMCID: PMC2009336  PMID: 4447785

Abstract

Serum concentrations of oestradiol-17β were measured daily throughout one menstrual cycle in 32 normal women, 31 women with benign disease of the breast and 10 with cancer of the breast. The concentrations were found to differ significantly from normal in women with cysts and to a lesser extent in those with cancer of the breast. In 25 normal post-menopausal and in 27 post-menopausal women with cancer repeated assays disclosed consistently low levels of oestradiol-17β.

Full text

PDF
571

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Argüelles A. E., Poggi U. L., Saborida C., Hoffman C., Chekherdemian M., Blanchard O. Endocrine profiles and breast cancer. Lancet. 1973 Jan 27;1(7796):165–168. doi: 10.1016/s0140-6736(73)90002-0. [DOI] [PubMed] [Google Scholar]
  2. Cameron E. H., Jones D. A. Some observations on the measurement of estradiol-17 in human plasma by radioimmunoassay. Steroids. 1972 Dec;20(6):737–759. doi: 10.1016/0039-128x(72)90055-4. [DOI] [PubMed] [Google Scholar]
  3. England P. C., Skinner L. G., Cottrell K. M., Sellwood R. A. Serum oestradiol-17 beta in normal women. Br J Cancer. 1974 Jun;29(6):462–469. doi: 10.1038/bjc.1974.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Foote F. W., Stewart F. W. Comparative Studies of Cancerous Versus Noncancerous Breasts. Ann Surg. 1945 Feb;121(2):197–222. doi: 10.1097/00000658-194502000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HODGE J., SURVER J., APONTE G. G. The relationship of fibrocystic disease to carcinoma of the breast: a study based on eight hundred seventy-six cases. Arch Surg. 1959 Oct;79:670–678. doi: 10.1001/archsurg.1959.04320100136023. [DOI] [PubMed] [Google Scholar]
  6. HUMPHREY L. J., SWERDLOW M. Relationship to benign breast disease to carcinoma of the breast. Surgery. 1962 Dec;52:841–846. [PubMed] [Google Scholar]
  7. Hayward J. Hormones and the aetiology of human breast cancer. Guys Hosp Rep. 1972;121(1):51–61. [PubMed] [Google Scholar]
  8. Lemon H. M., Wotiz H. H., Parsons L., Mozden P. J. Reduced estriol excretion in patients with breast cancer prior to endocrine therapy. JAMA. 1966 Jun 27;196(13):1128–1136. [PubMed] [Google Scholar]
  9. Lewison E. F. The pill, estrogens, and the breast. Clinical aspects. Cancer. 1971 Dec;28(6):1400–1403. doi: 10.1002/1097-0142(197112)28:6<1400::aid-cncr2820280611>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  10. MARMORSTON J., CROWLEY L. G., MYERS S. M., STERN E., HOPKINS C. E. II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE. Am J Obstet Gynecol. 1965 Jun 15;92:460–467. doi: 10.1016/s0002-9378(16)34835-9. [DOI] [PubMed] [Google Scholar]
  11. MacMahon B., Cole P., Brown J. Etiology of human breast cancer: a review. J Natl Cancer Inst. 1973 Jan;50(1):21–42. doi: 10.1093/jnci/50.1.21. [DOI] [PubMed] [Google Scholar]
  12. MacMahon B., Cole P. The ovarian etiology of human breast cancer. Recent Results Cancer Res. 1972;39:185–192. [PubMed] [Google Scholar]
  13. NISSEN-MEYER R., SANNER T. THE EXCRETION OF OESTRONE, PREGNANEDIOL AND PREGNANETRIOL IN BREAST CANCER PATIENTS. II. EFFECT OF OVARIECTOMY, OVARIAN IRRADIATION AND CORTICOSTEROIDS. Acta Endocrinol (Copenh) 1963 Nov;44:334–345. doi: 10.1530/acta.0.0440334. [DOI] [PubMed] [Google Scholar]
  14. PERSSON B. H., RISHOLM L. OOPHORECTOMY AND CORTISONE TREATMENT AS A METHOD OF ELIMINATING OESTROGEN PRODUCTION IN PATIENTS WITH BREAST CANCER. Acta Endocrinol (Copenh) 1964 Sep;47:15–26. doi: 10.1530/acta.0.0470015. [DOI] [PubMed] [Google Scholar]
  15. Rader M. D., Flickinger G. L., DeVilla G. O., Jr, Mikuta J. J., Mikhail G. Plasma estrogens in postmenopausal women. Am J Obstet Gynecol. 1973 Aug 15;116(8):1069–1073. doi: 10.1016/0002-9378(73)90938-1. [DOI] [PubMed] [Google Scholar]
  16. Schweppe J. S., Jungman R. A., Lewin I. Urine steroid excretion in postmenopausal cancer of the breast. Response to corticotropin stimulation and dexamethasone suppression. Cancer. 1967 Jan;20(1):155–163. doi: 10.1002/1097-0142(1967)20:1<155::aid-cncr2820200122>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES